These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 19910410

  • 1. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Manoharlal R, Gorantala J, Sharma M, Sanglard D, Prasad R.
    Microbiology (Reading); 2010 Feb; 156(Pt 2):313-326. PubMed ID: 19910410
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans.
    Manoharlal R, Gaur NA, Panwar SL, Morschhäuser J, Prasad R.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1481-92. PubMed ID: 18268086
    [Abstract] [Full Text] [Related]

  • 3. Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Shukla S, Yadav V, Mukhopadhyay G, Prasad R.
    Eukaryot Cell; 2011 Oct; 10(10):1357-66. PubMed ID: 21856931
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E, Hosseini Shokouh SJ, Rajabibazl M, Roudbary M, Rafiei S, Aslani P, Farahnejad Z.
    Br J Biomed Sci; 2016 Oct; 73(1):44-8. PubMed ID: 27182677
    [Abstract] [Full Text] [Related]

  • 8. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M, Morschhäuser J, Prasad R.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):206-14. PubMed ID: 15896319
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan 24; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Homozygosity at the Candida albicans MTL locus associated with azole resistance.
    Rustad TR, Stevens DA, Pfaller MA, White TC.
    Microbiology (Reading); 2002 Apr 24; 148(Pt 4):1061-1072. PubMed ID: 11932451
    [Abstract] [Full Text] [Related]

  • 16. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
    Holmes AR, Tsao S, Ong SW, Lamping E, Niimi K, Monk BC, Niimi M, Kaneko A, Holland BR, Schmid J, Cannon RD.
    Mol Microbiol; 2006 Oct 24; 62(1):170-86. PubMed ID: 16942600
    [Abstract] [Full Text] [Related]

  • 17. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.
    Mycoses; 2016 Feb 24; 59(2):93-100. PubMed ID: 26648048
    [Abstract] [Full Text] [Related]

  • 18. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
    Karnani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G, Prasad R.
    Yeast; 2004 Feb 24; 21(3):219-39. PubMed ID: 14968428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK, Thota CK, Verma SD, Sharma J, Rawal MK, Ravikumar B, Sen S, Chauhan N, Lynn AM, Chauhan VS, Prasad R.
    J Biol Chem; 2013 Jun 07; 288(23):16775-16787. PubMed ID: 23592791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.